Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14360-14360
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1071-1071
Open Access | Times Cited: 72
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3888-3888
Open Access | Times Cited: 69
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 4, pp. 297-313
Closed Access | Times Cited: 65
MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation
Giuseppe Lucarelli, Giuseppe Stefano Netti, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4814-4814
Open Access | Times Cited: 59
Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
Matteo Ferro, Gennaro Musi, Michele Marchioni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4615-4615
Open Access | Times Cited: 57
Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review
Achille Aveta, Simone Cilio, Roberto Contieri, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10846-10846
Open Access | Times Cited: 56
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16515-16515
Open Access | Times Cited: 50
The Role of MUC1 in Renal Cell Carcinoma
Martina Milella, Monica Rutigliano, Francesco Lasorsa, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 315-315
Open Access | Times Cited: 34
Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13179-13179
Open Access | Times Cited: 37
Urinary Micro-RNAs As Biomarkers of Urological Cancers: A Systematic Review
Achille Aveta, Simone Cilio, Roberto Contieri, et al.
(2023)
Open Access | Times Cited: 31
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors
Savio Domenico Pandolfo, Clara Cerrato, Zhenjie Wu, et al.
Asian journal of urology (2023) Vol. 10, Iss. 4, pp. 390-406
Open Access | Times Cited: 31
Identifying ADME-related gene signature for immune landscape and prognosis in KIRC by single-cell and spatial transcriptome analysis
Hongyun Wang, Fa-Jie Li, Qiong Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Transcriptomic and proteo-metabolic determinants of the grading system in clear cell renal cell carcinoma
Giuseppe Lucarelli, Francesco M. Lasorsa, Martina Milella, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Open Access | Times Cited: 1
Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up
Savio Domenico Pandolfo, Alp Tuna Beksaç, Ithaar Derweesh, et al.
Journal of Endourology (2022) Vol. 37, Iss. 3, pp. 279-285
Closed Access | Times Cited: 33
Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives
Luigi Napolitano, Celeste Manfredi, Luigi Cirillo, et al.
Medicina (2023) Vol. 59, Iss. 4, pp. 767-767
Open Access | Times Cited: 16
Endoplasmic Reticulum Stress in Renal Cell Carcinoma
Marta Correia de Sousa, Etienne Delangre, Miranda Türkal, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4914-4914
Open Access | Times Cited: 15
Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature
Alexius John, Lavinia Spain, Anis Hamid
Current Oncology (2023) Vol. 30, Iss. 1, pp. 923-937
Open Access | Times Cited: 13
Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles
Konrad Grützmann, Karsten Salomo, Alexander Krüger, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
The Role of the L-Arginine–Nitric Oxide Molecular Pathway in Autosomal Dominant Polycystic Kidney Disease
Corina Daniela Ene, Mircea Penescu, Ilinca Nicolae, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 3, pp. 299-299
Open Access | Times Cited: 4
Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC
Lijie Zhou, Youmiao Zeng, Y F Liu, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients
Lei Ren, Jinwen Liu, Qingyuan Lin, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and Prognosis
Xiaoyu Xu, Yuzheng Fang, Qirui Wang, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Bioinformatics analysis of mitochondrial metabolism-related genes demonstrates their importance in renal cell carcinoma
Mohsen Ahmadi, Maryam Motallebinezhad, Pegah Mousavi, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma
J. H. Jespersen, Cecilie Lindgaard, Laura Iisager, et al.
Nature Reviews Urology (2025)
Closed Access
Efficient extraction via titanium organic frameworks facilitates in-depth profiling of urinary exosome metabolite fingerprints
Yijie Chen, Man Zhang, Yu Qi, et al.
Analytical and Bioanalytical Chemistry (2025)
Closed Access
Page 1 - Next Page

Scroll to top